Boston Scientific Announces Results for First Quarter 2015

Go back to Boston Scientific Announces Results for First Quarter 2015

Boston Scientific (BSX) PT Raised to $21 at Leerink Partners Following Q1

April 29, 2015 8:57 AM EDT

Leerink Partners analyst Danielle Antalffy reiterated an Outperform rating and boosted its price target Boston Scientific (NYSE: BSX) price target of $21.00 (from $18.00) following Q1 results and solid 2015 outlook.

Antalffy commented, "Over the last two years, BSX's turnaround story has steadily played out, with new management delivering... More

Boston Scientific (BSX) Reports In-Line Q1 EPS

April 28, 2015 7:01 AM EDT

Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.78 billion.

Boston Scientific sees FY2015 EPS of $0.88-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue... More